BMC Pulmonary Medicine

unofficial impact factor 1.91

Open Access Research article

Long acting β2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials

Don Husereau*, Vijay Shukla, Michel Boucher, Shaila Mensinkai and Robert Dales

  • * Corresponding author: Don Husereau donh@ccohta.ca

  • † Equal contributors

BMC Pulmonary Medicine 2004, 4:7 doi:10.1186/1471-2466-4-7

No comments have yet been made on this article.

Post a comment